IP that has yet to be known, that will lead to marketable products has also huge potential value. BP can help unleash this.
Neuron needs a big partner to quickly exploit what is, much needed medicine on a scale too big for Neuron to take on to get it out there to those that need it, now.In this instance the world needs a far reaching medical network. Hopefully a huge ( American) BH will approach Neu. 2c
Bristol Myers to acquire Karuna for $14Billion, page-9
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.29 |
Change
-0.270(1.85%) |
Mkt cap ! $1.817B | |||
| Open | High | Low | Value | Volume |
| $14.38 | $14.42 | $14.11 | $1.505M | 105.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 196 | $14.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.30 | 381 | 7 |
View Market Depth
| Last trade - 11.48am 04/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |